Helping Blood Donors With High Cholesterol Get Treatment
Tests a support package to improve cholesterol care in adult blood donors with familial hypercholesterolemia.
Key facts
- Who runs it
- University of Texas Southwestern Medical Center
- Where
- Dallas, United StatesSee the site
- Trial code
- Registry title
- Multicomponent Intervention Study- Blood Donors With High Cholesterol
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 27 Feb 2023
- Expected to end
- 30 Apr 2027
- Type of study
- Interventional, 2 groups
- Treatments tested
- Implementation Strategy Bundle
- Usual care notification
- Record updated
- 17 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for blood donors from Carter BloodCare who have high cholesterol meeting MEDPED FH criteria (familial hypercholesterolemia).
- Age
- 18 to 75 years
- Sex
- All sexes can join.
- Disease stage
- High cholesterol meeting MEDPED FH criteria (familial hypercholesterolemia).
- Earlier treatment
- People currently taking medication to lower cholesterol cannot join.
Main reasons for not taking part
- Currently taking medication to lower cholesterol
- Taking any medication that can interact with statins
- Pregnancy
- Identified secondary cause of elevated lipids
- Chronic liver disease or significantly elevated liver function tests (> 3 times upper limit)
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Blood donors from Carter BloodCare with high cholesterol meeting MEDPED FH criteria
- Age 18 to 75 years
Who cannot take part
- Currently taking medication to lower cholesterol
- Taking any medication that can interact with statins
- Chronic liver disease or significantly elevated liver function tests (> 3 times upper limit)
- Pregnancy
- Identified secondary cause of elevated lipids
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Where in United States
- UT Southwestern Medical CenterDallas, United StatesContact: Lakeisha CadeTaking people
About the trial
What the trial wants to find out
The purpose and objective of this study is to improve cholesterol treatment among blood donors with FH (Familial Hypercholesterolemia).
The 2 groups in the trial
- Control group (Usual care)Other group
This arm will receive standard notification that is usually provided by Carter describing need to review with donor's primary care physician the presence of high cholesterol
Treatment: Usual care notification
- Intervention Group (Implementation strategy bundle)Treatment being tested
Along with standard high cholesterol notification from Carter BloodCare, this arm will receive Implementation strategy bundle (educational material regarding high cholesterol levels)
Treatment: Implementation Strategy Bundle and Usual care notification
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Implementing a Multicomponent Intervention to Treat Blood Donors With Familial Hypercholesterolemia
- Plain-language title
- Helping Blood Donors With High Cholesterol Get TreatmentGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT05693701, who can take part
- Record updated
- 17 March 2026